Please login to the form below

Not currently logged in
Email:
Password:

commercial

This page shows the latest commercial news and features for those working in and with pharma, biotech and healthcare.

NHS England sees off AbbVie's Hep C legal challenge

NHS England sees off AbbVie's Hep C legal challenge

Within weeks however, the company had agreed an ‘interim commercial offer’.

Latest news

More from news
Approximately 1 fully matching, plus 1,261 partially matching documents found.

Latest Intelligence

  • The UK’s new five-year pricing agreement The UK’s new five-year pricing agreement

    Commercial arrangements. Opportunities for greater commercial flexibility for those companies that offer the best value new medicines, negotiated with NHS England. ... Confidential sharing of commercial arrangements across the UK, with all four countries

  • Escaping the spin cycle of sub-optimal launch Escaping the spin cycle of sub-optimal launch

    Research suggests that fewer than a third of new products meet commercial expectations, with 72% falling short of revenue targets. ... Marketers and commercials teams have to be the Standard Bearers; the Troop Ralliers; the Team Motivators.

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    Of those drugs that are approved, roughly 30% will see commercial success. ... That’s leading to new metrics that redefine performance. For companies focused on a first or second commercial drug, those metrics also support an additional strategic

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    The clinical and commercial success of these three cancer therapies has helped restore self-belief among AstraZeneca employees, and will help make 2019 the year the company returns to top-line ... So how did AstraZeneca achieve this turnaround? In 2010

  • Diagnosed Anywhere Diagnosed Anywhere

    The creation of the Health Trend Ten was led by Leigh Householder, with contributions from a team of 200+ clinical and commercial minds across the company.

More from intelligence
Approximately 0 fully matching, plus 247 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 319 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 369 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics